Standard Chem & Pharm CO., LTD.

Taiwan Stock Exchange 1720.TW

Standard Chem & Pharm CO., LTD. Operating Income Margin for the year ending December 31, 2023: 20.19%

Standard Chem & Pharm CO., LTD. Operating Income Margin is 20.19% for the year ending December 31, 2023, a -17.78% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Standard Chem & Pharm CO., LTD. Operating Income Margin for the year ending December 31, 2022 was 24.55%, a 10.61% change year over year.
Standard Chem & Pharm CO., LTD. Operating Income Margin for the year ending December 31, 2021 was 22.20%, a 23.46% change year over year.
Standard Chem & Pharm CO., LTD. Operating Income Margin for the year ending December 31, 2020 was 17.98%, a 19.93% change year over year.
Standard Chem & Pharm CO., LTD. Operating Income Margin for the year ending December 31, 2019 was 14.99%, a 34.33% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

Taiwan Stock Exchange: 1720.TW

Standard Chem & Pharm CO., LTD.

CEO	Mr. Tzu-Ting Fan
IPO Date	Jan. 4, 2000
Location	Taiwan
Headquarters	No. 6-20, Tuku
Employees	1,130
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Standard Chem & Pharm CO., LTD. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan. It offers various pharmaceutical products, including circulatory system, digestive system, respiratory system, antihistamine, C.N.S, metabolism, anti-microbial, and skin and mucous membrane drugs, as well as human and veterinary APIs, and excipients. The company was founded in 1967 and is headquartered in Tainan City, Taiwan.

Key trends

Past 5 years